Pfizer and Lilly osteoarthritis pain drug grabs another win

The pair of drugmakers announced that its drug tanezumab reduced pain significantly at the higher of two doses tested, with a phase 3 trial from last year also showing efficacy
Source: PharmaManufacturing.com - Category: Pharmaceuticals Source Type: news